IMNN
Imunon·NASDAQ
--
--(--)
--
--(--)
IMNN fundamentals
Imunon (IMNN) released its earnings on Nov 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -1.16 (YoY +73.84%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-1.16
+73.84%
Report date
Nov 13, 2025
IMNN Earnings Call Summary for Q3,2025
- OVATION 3 Enrollment Surging: 9 patients randomized by October 2025, exceeding internal targets.
- Cost Efficiency: 31% YoY drop in operating expenses, $1.25M monthly cash burn.
- Adaptive Trial Design: 95% statistical power with interim stopping rules for accelerated approval.
- Regulatory Momentum: FDA-endorsed overall survival endpoint, European alignment in sight.
- Partnership Progress: Active discussions with pharma companies for non-dilutive funding.
Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
Imunon (IMNN) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Imunon (IMNN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Imunon (IMNN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Imunon (IMNN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Imunon (IMNN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Imunon (IMNN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Imunon's latest dividend and current dividend yield?What guidance did Imunon's management provide for the next earnings period?Did Imunon beat or miss consensus estimates last quarter?What is the market's earnings forecast for Imunon next quarter?What does Imunon do and what are its main business segments?What factors drove the changes in Imunon's revenue and profit?What is Imunon's gross profit margin?What were the key takeaways from Imunon's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
